Beta Drugs
2,073.30
+20.30(+0.99%)
Market Cap₹2,305.77 Cr
PE Ratio49.19
IndustryHealthcare
Company Performance:
1D+0.99%
1M-5.80%
6M+74.33%
1Y+13.93%
5Y+360.73%
View Company Insightsright
Latest news about Beta Drugs
Beta Drugs gets Azerbaijan approval for oncology products, eyes FY27 sales 10 days ago
Beta Drugs received regulatory approval from Azerbaijan for its oncology products. The company aims to commence sales from this approval in FY27. The development expands Beta Drugs' international presence in the oncology segment.
no imag found